RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Repurchases of common stock

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndRepurchases of common stock (Million USD)YoY (%)
Jun 30, 2025300+100.00%
Jun 30, 2024150+556.68%
Jun 30, 201923-57.54%
Jun 30, 201854-47.28%
Jun 30, 2016102-36.33%
Jun 30, 2015160-20.71%
Jun 30, 2014202+8.54%
Jun 30, 2013186-52.58%
Jun 30, 2012393+140.44%
Jun 30, 2011163

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)